Facial redness in Japanese adolescents with atopic dermatitis treated with dupilumab: A case series

This case series study is the first report of Japanese adolescents who experienced dupilumab facial redness after starting dupilumab treatment for refractory atopic dermatitis. In every case, dupilumab facial redness subsided without discontinuation of dupilumab within 3 months after onset.

Détails bibliographiques

Auteurs principaux:	Shuhei Hara, MD, Takaaki Itonaga, MD, Makoto Nishino, MD, Noriyuki Yanagida, MD, PhD, Sakura Sato, MD, Motohiro Ebisawa, MD, PhD
Format:	Artigo
Langue:	Inglês
Publié:	Elsevier 2023-05-01
Collection:	Journal of Allergy and Clinical Immunology: Global
Sujets:	Atopic dermatitis dupilumab Japanese adolescent erythema
Accès en ligne:	http://www.sciencedirect.com/science/article/pii/S2772829323000218
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!